Search Results - "Palmese, Laura B"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Insomnia is frequent in schizophrenia and associated with night eating and obesity by Palmese, Laura B, DeGeorge, Pamela C, Ratliff, Joseph C, Srihari, Vinod H, Wexler, Bruce E, Krystal, Andrew D, Tek, Cenk

    Published in Schizophrenia research (01-12-2011)
    “…Abstract Background Sleep difficulties are common in schizophrenia, however these complaints are often overshadowed by more prominent clinical concerns. The…”
    Get full text
    Journal Article
  2. 2

    The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: A double-blind, randomized, placebo-controlled trial by Tek, Cenk, Palmese, Laura B, Krystal, Andrew D, Srihari, Vinod H, DeGeorge, Pamela C, Reutenauer, Erin L, Guloksuz, Sinan

    Published in Schizophrenia research (01-12-2014)
    “…Abstract Background Insomnia is frequent in schizophrenia and may contribute to cognitive impairment as well as overuse of weight inducing sedative…”
    Get full text
    Journal Article
  3. 3

    High Rates of Obstructive Sleep Apnea Symptoms Among Patients With Schizophrenia by Annamalai, Aniyizhai, M.D, Palmese, Laura B., Psy.D, Chwastiak, Lydia A., M.D., M.P.H, Srihari, Vinod H., M.D, Tek, Cenk, M.D

    Published in Psychosomatics (Washington, D.C.) (01-01-2015)
    “…Background Patients with schizophrenia have high rates of obesity and cardiovascular morbidity, which are strongly associated with obstructive sleep apnea…”
    Get full text
    Journal Article
  4. 4

    Obese Schizophrenia Spectrum Patients Have Significantly Higher 10-Year General Cardiovascular Risk and Vascular Ages than Obese Individuals without Severe Mental Illness by Ratliff, Joseph C., Ph.D, Palmese, Laura B., Psy.D, Reutenauer, Erin L., B.A, Srihari, Vinod H., M.D, Tek, Cenk, M.D

    Published in Psychosomatics (Washington, D.C.) (01-01-2013)
    “…Background Individuals with schizophrenia have a life expectancy that is 20 years less than the general population, along with high rates of obesity and…”
    Get full text
    Journal Article
  5. 5

    The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study by Ratliff, Joseph C, Palmese, Laura B, Reutenauer, Erin L, Liskov, Ellen, Grilo, Carlos M, Tek, Cenk

    Published in Comprehensive psychiatry (01-10-2012)
    “…Abstract Objective With the rate of obesity on the rise worldwide, individuals with schizophrenia represent a particularly vulnerable population. The aim of…”
    Get full text
    Journal Article
  6. 6

    Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination Survey by Ratliff, Joseph C., Barber, Jessica A., Palmese, Laura B., Reutenauer, Erin L., Tek, Cenk

    Published in Obesity (Silver Spring, Md.) (01-12-2010)
    “…The incidence of obesity in the United States has reached epidemic proportions. Previous research has shown several medications exert noticeable effects on…”
    Get full text
    Journal Article
  7. 7

    Prevalence of night eating in obese individuals with schizophrenia and schizoaffective disorder by Palmese, Laura B, Ratliff, Joseph C, Reutenauer, Erin L, Tonizzo, K. Melek, Grilo, Carlos M, Tek, Cenk

    Published in Comprehensive psychiatry (01-04-2013)
    “…Abstract The prevalence of Night Eating Syndrome (NES) in the general population is estimated to be 1.5%, however, the rates among individuals with…”
    Get full text
    Journal Article
  8. 8

    An open-label pilot trial of alpha-lipoic acid for weight loss in patients with schizophrenia without diabetes by Ratliff, Joseph C, Palmese, Laura B, Reutenauer, Erin L, Tek, Cenk

    Published in Clinical schizophrenia & related psychoses (01-01-2015)
    “…A possible mechanism of antipsychotic-induced weight gain is activation of hypothalamic monophosphate-dependent kinase (AMPK) mediated by histamine 1…”
    Get more information
    Journal Article
  9. 9

    Contingency Management for the Treatment of Antipsychotic-Induced Weight Gain: A Randomized Controlled Pilot Study by Ratliff, Joseph C., Palmese, Laura B., Tonizzo, K.Melek, Chwastiak, Lydia, Tek, Cenk

    Published in Obesity facts (01-12-2012)
    “…Objective: Weight gain is common for individuals with serious mental illness (SMI) receiving antipsychotic drug therapy. Contingency management (CM) is a…”
    Get full text
    Journal Article
  10. 10

    Misattribution of affect to neutral stimuli: Types of error among individuals with paranoid schizophrenia by Palmese, Laura B

    Published 01-01-2009
    “…A defining feature of schizophrenia is a deficit in social functioning, and paramount among these is the inability to correctly identify emotion in others…”
    Get full text
    Dissertation